$SEER
Seer, Inc. Stock $seer

$seer Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000162828023016850 Filed on May 09, 2023

Income Statement

Concept	2023 Q1	2022 Q4
Revenue	$4.053M	$4.605M
YoY Change	22.37%	50.2%
Cost Of Revenue	$1.985M	$2.310M
YoY Change	-4.01%	41.46%
Gross Profit	$2.068M	$2.295M
YoY Change	66.24%	60.15%
Gross Profit Margin	51.02%	49.84%
Selling, General & Admin	$15.04M	$14.61M
YoY Change	5.18%	11.63%
% of Gross Profit	727.22%	636.78%
Research & Development	$14.47M	$12.63M
YoY Change	34.87%	53.74%
% of Gross Profit	699.9%	550.33%
Depreciation & Amortization	$1.200M	$1.103M
YoY Change	33.33%	31.94%
% of Gross Profit	58.03%	48.06%
Operating Expenses	$29.51M	$27.24M
YoY Change	17.91%	27.86%
Operating Profit	-$27.45M	-$24.95M
YoY Change	15.38%	25.54%
Interest Expense	$3.717M	$2.497M
YoY Change	2481.25%	1749.63%
% of Operating Profit
Other Income/Expense, Net	$3.486M	-$73.00K
YoY Change	2390.0%
Pretax Income	-$23.96M	-$22.53M
YoY Change	1.32%	14.11%
Income Tax
% Of Pretax Income
Net Earnings	-$23.96M	-$22.53M
YoY Change	1.32%	14.11%
Net Earnings / Revenue	-591.14%	-489.14%
Basic Earnings Per Share	-$0.38
Diluted Earnings Per Share	-$0.38	-$0.36
COMMON SHARES
Basic Shares Outstanding	63.54M shares
Diluted Shares Outstanding	63.54M shares

Balance Sheet

Concept	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$352.1M	$421.2M
YoY Change	-20.92%	5.29%
Cash & Equivalents	$48.39M	$53.21M
Short-Term Investments	$303.7M	$368.0M
Other Short-Term Assets	$4.380M	$2.098M
YoY Change	3.77%	-37.11%
Inventory	$3.718M	$4.627M
Prepaid Expenses	$4.380M	$2.098M
Receivables	$4.735M	$4.315M
Other Receivables	$1.065M	$899.0K
Total Short-Term Assets	$367.4M	$435.0M
YoY Change	-19.69%	5.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.68M	$19.41M
YoY Change	36.77%	48.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$58.42M	$5.157M
YoY Change	120.02%	-94.47%
Other Assets	$853.0K	$855.0K
YoY Change	74.08%	70.66%
Total Long-Term Assets	$105.4M	$52.95M
YoY Change	51.39%	-58.45%
TOTAL ASSETS
Total Short-Term Assets	$367.4M	$435.0M
Total Long-Term Assets	$105.4M	$52.95M
Total Assets	$472.8M	$487.9M
YoY Change	-10.3%	-9.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.956M	$2.104M
YoY Change	-40.57%	-44.47%
Accrued Expenses	$7.175M	$8.298M
YoY Change	12.51%	-1.14%
Deferred Revenue	$263.0K	$133.0K
YoY Change	-33.25%	-64.63%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.75M	$12.58M
YoY Change	5.4%	-6.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$360.0K	$320.0K
YoY Change	5.57%	-6.16%
Total Long-Term Liabilities	$360.0K	$320.0K
YoY Change	5.57%	-6.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.75M	$12.58M
Total Long-Term Liabilities	$360.0K	$320.0K
Total Liabilities	$39.80M	$40.94M
YoY Change	-2.04%	13.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$243.5M	-$219.5M
YoY Change	62.12%	73.48%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$433.0M	$447.0M
YoY Change
Total Liabilities & Shareholders Equity	$472.8M	$487.9M
YoY Change	-10.3%	-9.5%

Cashflow Statement

Concept	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	-$23.96M	-$22.53M
YoY Change	1.32%	14.11%
Depreciation, Depletion And Amortization	$1.200M	$1.103M
YoY Change	33.33%	31.94%
Cash From Operating Activities	-$19.33M	-$14.26M
YoY Change	0.94%	15.26%
INVESTING ACTIVITIES
Capital Expenditures	$121.0K	$4.973M
YoY Change	-88.8%	-472.79%
Acquisitions
YoY Change
Other Investing Activities	$14.60M	$2.262M
YoY Change	21.67%	-102.63%
Cash From Investing Activities	$14.48M	-$2.711M
YoY Change	32.59%	-96.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$30.00K	2.106M
YoY Change	-96.01%	65.96%
NET CHANGE
Cash From Operating Activities	-$19.33M	-14.26M
Cash From Investing Activities	$14.48M	-2.711M
Cash From Financing Activities	$30.00K	2.106M
Net Change In Cash	-$4.822M	-14.86M
YoY Change	-35.53%	-84.93%
FREE CASH FLOW
Cash From Operating Activities	-$19.33M	-$14.26M
Capital Expenditures	$121.0K	$4.973M
Free Cash Flow	-$19.45M	-$19.23M
YoY Change	-3.85%	74.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001726445
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39747
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SEER, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-1153150
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3800 Bridge Parkway
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 102
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Redwood City
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4315000	usd
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94065
CY2023Q1	dei	City Area Code CityAreaCode	650
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	453-0000
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.00001
CY2023Q1	dei	Trading Symbol TradingSymbol	SEER
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48386000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53208000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	303708000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	368031000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4735000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1200000	usd
CY2023Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1383000	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1804000	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1065000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	899000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3718000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4627000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4380000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2098000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	367375000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	434982000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	58416000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	5157000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26944000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27003000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18675000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19408000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	524000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	524000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	853000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	855000	usd
CY2023Q1	us-gaap	Assets Assets	472787000	usd
CY2022Q4	us-gaap	Assets Assets	487929000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	1956000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	2104000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7175000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8298000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	263000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	133000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2188000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1842000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	172000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	207000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	11754000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12584000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27684000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28032000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	360000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	320000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	39798000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	40936000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Depreciation Depreciation	900000	usd
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	676536000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	667739000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-93000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1251000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-243455000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-219496000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	432989000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	446993000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	472787000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	487929000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4053000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3312000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1985000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	2068000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	2068000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1244000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14474000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10732000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15039000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14298000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	29513000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	25030000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27445000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23786000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3717000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	144000	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	231000	usd
CY2022Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3486000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	140000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-23959000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-23646000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1158000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1691000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22801000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25337000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63543094	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63543094	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63543094	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63543094	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62003504	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62003504	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	446993000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30000	usd
CY2023Q1	seer	Stock Issued During Period Value Stock Options Early Exercised StockIssuedDuringPeriodValueStockOptionsEarlyExercised	43000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8724000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1158000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-23959000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-23959000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	432989000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	502916000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	773000	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	usd
CY2022Q1	seer	Stock Issued During Period Value Stock Options Early Exercised StockIssuedDuringPeriodValueStockOptionsEarlyExercised	44000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8062000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1691000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-23646000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	486458000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-23959000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-23646000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8724000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8062000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1249000	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	875000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-226000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-2378000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	314000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	178000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	57000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	597000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	420000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	298000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-421000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-157000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	166000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	174000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2282000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2850000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	40000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-300000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-11000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-100000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-479000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	130000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	18000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-985000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2038000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-35000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	47000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19331000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19151000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	121000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1080000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	134520000	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2990000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	146130000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	12000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14479000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10920000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	21000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	773000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	752000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4822000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7479000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53732000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233337000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48910000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	225858000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	771000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	635000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	514000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6855000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	352100000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-243500000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and the disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates and assumptions, including, but not limited to, those related to the determination of stand-alone selling price for revenue recognition, the fair value of common stock, stock-based compensation, accrued research and development expenses, allowance for credit losses, inventory valuation, useful lives and valuation of property and equipment, income tax uncertainties, and tax valuation allowances.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from those estimates.</span></div>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, and investments. The Company maintains bank deposits in federally insured </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial institutions, and these deposits may exceed federally insured limits. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash and cash equivalents and issuers of investments to the extent account balances exceed the amount insured by the Federal Deposit Insurance Corporation (FDIC). On March 10, 2023, Silicon Valley Bank (SVB) was closed by the California Department of Financial Protection and Innovation and the FDIC was appointed as receiver. On March 27, 2023, First-Citizens Bank & Trust Company assumed all of SVB's deposits and loans. In light of the foregoing, the Company does not believe that it has exposure to loss as a result of SVB’s receivership. As of March 31, 2023, the Company held $0.8 million in SVB and has not experienced any losses on its deposits of cash, cash equivalents and investments.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 and 2022, the Company recognized revenue from a related party that represented 32% of the Company’s total revenue. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023, 22% of the total revenue was generated outside of the United States, primarily from countries in Asia and Europe. For the three months ended March 31, 2022, 25% of the total revenue was generated outside of the United States, primarily from countries in Asia and Europe.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023 and December 31, 2022, there was one related party customer which represented 23% and 25%, respectively, of the total accounts receivable balance. As of December 31, 2022, there were two additional customers which represented 10% and 12% of the total accounts receivable balance.</span></div>
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48386000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53208000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	524000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	524000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48910000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53732000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	30000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	410605000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	292000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	387000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	410510000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	427647000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	40000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1291000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	426396000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	100000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	100000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	58400000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Term DebtSecuritiesAvailableForSaleTerm	P1Y
CY2023Q1	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	700000	usd
CY2022Q4	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	600000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1592000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2129000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	205000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	271000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1921000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2227000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3718000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4627000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27057000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27229000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8382000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7821000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18675000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19408000	usd
CY2023Q1	seer	Accrued Compensation AccruedCompensation	3806000	usd
CY2022Q4	seer	Accrued Compensation AccruedCompensation	6139000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	458000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	322000	usd
CY2023Q1	seer	Accrued Property And Equipment AccruedPropertyAndEquipment	198000	usd
CY2022Q4	seer	Accrued Property And Equipment AccruedPropertyAndEquipment	300000	usd
CY2023Q1	seer	Accrued Research And Development AccruedResearchAndDevelopment	259000	usd
CY2022Q4	seer	Accrued Research And Development AccruedResearchAndDevelopment	235000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	790000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	335000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1664000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	967000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7175000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8298000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	133000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	376000	usd
CY2023Q1	seer	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	614000	usd
CY2022Q1	seer	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	233000	usd
CY2023Q1	seer	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	441000	usd
CY2022Q1	seer	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	476000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	306000	usd
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	133000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3100000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.77
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q1	seer	Lessee Incremental Borrowing Rate LesseeIncrementalBorrowingRate	0.062
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	105000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63739319	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63739319	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63411046	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63411046	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3846000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3957000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10214430	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.90
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2247900	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.60
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	13595	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.20
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	101825	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	12.77
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12346910	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.23
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	5241662	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	8.76
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4072000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8724000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8062000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Number Of Employees Affected ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected	1	planparticipant
CY2022Q1	seer	Share Based Compensation Arrangement By Share Based Payment Award Options Modifications To Extend Term And Vesting Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsModificationsToExtendTermAndVestingShares	1330892	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	900000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P8Y
CY2022Q2	us-gaap	Share Price SharePrice	7.40
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2023Q1	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P5Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M24D
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1038000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	813000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	161000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	194000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	69000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	1209000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	1076000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2961000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3969000	usd
CY2023Q1	seer	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	21065000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	39870000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9998000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	29872000	usd
CY2023Q1	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	40000	usd
CY2022Q1	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	0	usd
CY2023Q1	us-gaap	Purchase Obligation PurchaseObligation	4300000	usd
CY2022Q4	us-gaap	Purchase Obligation PurchaseObligation	5700000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-23959000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-23646000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63543094	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63543094	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63543094	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63543094	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62003504	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62003504	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15841311	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13644277	shares

Files In Submission

Name	View Source	Status
0001628280-23-016850-index-headers.html	Edgar Link	pending
0001628280-23-016850-index.html	Edgar Link	pending
0001628280-23-016850.txt	Edgar Link	pending
0001628280-23-016850-xbrl.zip	Edgar Link	pending
a311ceo-certificationpursu.htm	Edgar Link	pending
a312cfo-certificationpursu.htm	Edgar Link	pending
a321ceo-certificationpursu.htm	Edgar Link	pending
a322cfo-certificationpursu.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
outsidedirectorcompensatio.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
seer-20230331.htm	Edgar Link	pending
seer-20230331.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
seer-20230331_def.xml	Edgar Link	unprocessable
seer-20230331_cal.xml	Edgar Link	unprocessable
seer-20230331_lab.xml	Edgar Link	unprocessable
seer-20230331_pre.xml	Edgar Link	unprocessable
seer-20230331_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SEER
Seer, Inc. Stock $seer

2023 Q1 Form 10-Q Financial Statement

#000162828023016850 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEER Seer, Inc. Stock $seer

2023 Q1 Form 10-Q Financial Statement

#000162828023016850 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEER
Seer, Inc. Stock $seer